Endoscopic mucosal resection for staging and therapy of adenocarcinoma of the esophagus, gastric cardia, and upper gastric third.
Minamally invasive endoscopic resection techniques allow definitive histological staging for dysplasia and early cancer and in many cases curative treatment. In Barrett's esophagus with High Grade Dysplasia (HGD) or early mucosal cancer, endoscopic mucosal resection (EMR) should be considered both as diagnostic and therapeutic first line procedure, with the possibility to repeat the procedure in case of residual Barrett's dysplasia or mucosal cancer. In early cancer of the the submucosa, surgical resection should be discussed. Endoscopic submucosal dissection (ESD) is a useful therapeutic option for HGD or early cancer in the squamous epithelium of the esophagus or in the stomach when en bloc resection is needed in large lesions.
Heinrich
Henriette
H
Department of Hepatology and Gastroenterology, University of Züerich, Züerich, Switzerland. henriette.heinrich@usz.ch
Bauerfeind
Peter
P
D000230:Adenocarcinoma / Q000473:pathology* / Q000628:therapy; D001471:Barrett Esophagus / Q000473:pathology; D002299:Cardia; D004724:Endoscopy; D004938:Esophageal Neoplasms / Q000473:pathology* / Q000628:therapy; D004943:Esophagogastric Junction / Q000473:pathology; D006801:Humans; D009092:Mucous Membrane / Q000473:pathology / Q000601:surgery; D009367:Neoplasm Staging; D013274:Stomach Neoplasms / Q000473:pathology* / Q000628:therapy